The Centre for Covid-19 Situation Administration on Monday approved a plan to procure a combined 3.35 million doses of Covid-19 vaccines manufactured by AstraZeneca and by Pfizer and BioNTech, a spokesperson said.
Should the Cabinet grant final approval, 165,000 AstraZeneca doses and 2.79 million Pfizer-BioNTech doses would be procured from Spain and 400,000 AstraZeneca doses from Hungary, the spokesperson said.
No timeframe for delivery was provided.